no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer
|
Lee, Jae Jin |
|
2008 |
63 |
6 |
p. 1083-1090 |
article |
2 |
A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
|
Schelman, William R. |
|
2008 |
63 |
6 |
p. 1147-1156 |
article |
3 |
Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer
|
Nakamura, Masaru |
|
2008 |
63 |
6 |
p. 1091-1096 |
article |
4 |
Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells
|
Tian, Ze |
|
2008 |
63 |
6 |
p. 1131-1139 |
article |
5 |
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines
|
Duan, Zhenfeng |
|
2008 |
63 |
6 |
p. 1121-1129 |
article |
6 |
Dual targeting of EGFR and HER-2 in colon cancer cell lines
|
Giannopoulou, Efstathia |
|
2008 |
63 |
6 |
p. 973-981 |
article |
7 |
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile
|
Mercier, Cedric |
|
2008 |
63 |
6 |
p. 1177-1180 |
article |
8 |
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany
|
Gerullis, Holger |
|
2008 |
63 |
6 |
p. 1097-1102 |
article |
9 |
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
|
Colozza, Mariantonietta |
|
2008 |
63 |
6 |
p. 1157-1159 |
article |
10 |
5-FU pretreatment potentiates cisplatin-induced apoptosis through up-regulation of thrombospondin-1 in head and neck squamous cell carcinomas
|
Xu, Bei |
|
2008 |
63 |
6 |
p. 1181-1183 |
article |
11 |
Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells
|
Queiroz, Alexandre F. S. |
|
2008 |
63 |
6 |
p. 1023-1033 |
article |
12 |
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer
|
Yi, Seong Yoon |
|
2008 |
63 |
6 |
p. 1141-1145 |
article |
13 |
Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose
|
Breccia, Massimo |
|
2008 |
63 |
6 |
p. 1161-1163 |
article |
14 |
Lack of toxicity of a STAT3 decoy oligonucleotide
|
Sen, Malabika |
|
2008 |
63 |
6 |
p. 983-995 |
article |
15 |
Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction
|
Kumar, Gondi |
|
2008 |
63 |
6 |
p. 1171-1175 |
article |
16 |
Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy
|
Takane, Hiroshi |
|
2008 |
63 |
6 |
p. 1165-1169 |
article |
17 |
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients
|
Bulitta, Jürgen B. |
|
2008 |
63 |
6 |
p. 1049-1063 |
article |
18 |
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
|
Chiarion-Sileni, Vanna |
|
2008 |
63 |
6 |
p. 1111-1119 |
article |
19 |
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients
|
Bulitta, Jürgen B. |
|
2008 |
63 |
6 |
p. 1035-1048 |
article |
20 |
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
|
Xu, Y. |
|
2008 |
63 |
6 |
p. 1073-1082 |
article |
21 |
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
|
Lin, Chia-Chi |
|
2008 |
63 |
6 |
p. 1065-1071 |
article |
22 |
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
|
Yuan, Jianhui |
|
2008 |
63 |
6 |
p. 1103-1110 |
article |
23 |
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression
|
Liu, Hongli |
|
2008 |
63 |
6 |
p. 997-1005 |
article |
24 |
Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells
|
Loa, Jacky |
|
2008 |
63 |
6 |
p. 1007-1016 |
article |
25 |
Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature
|
Saif, Muhammad Wasif |
|
2008 |
63 |
6 |
p. 1017-1022 |
article |